TAAV BIOMANUFACTURING SOLUTIONS

We provide the first option for critical starting material for AAV production. neDNA™ is an enzymatic DNA designed to transform and accelerate the traditional gene therapy development timelines Enzymatic manufacturing removes significant levels of bacterial contaminants, resulting in the production of enzymatic DNA product with an improved safety profile for the manufacture of recombinant adeno-associated virus (rAAV) gene therapy vectors.

Brands: TAAV is advancing gene therapy by offering neDNA™: an enzymatic linear, double stranded DNA as the new industry standard for transfection-based rAAV production.